REVIEW PAPER
Nephrocalcinosis: the latest reports on risk factors –
a review
More details
Hide details
1
Faculty Medicine, Medical University of Wrocław, Wrocaw, Poland
These authors had equal contribution to this work
Submission date: 2024-03-12
Final revision date: 2024-05-03
Acceptance date: 2024-05-10
Publication date: 2024-09-20
Corresponding author
Tomasz Dudzik
Faculty Medicine, Medical University of Wrocław, Wybrzeże L. Pasteura 1, 50-367 Wrocław, Poland
Pediatr Pol 2024;99(3):240-345
KEYWORDS
TOPICS
ABSTRACT
This review synthesizes recent discoveries in the risk factors of nephrocalcinosis, with a particular focus on novel f indings. Nephrocalcinosis, characterized by the deposition of calcium salts in the renal parenchyma, is linked to a variety of genetic, metabolic, dietetic, and environmental factors. The study emphasizes the critical role of advanced imaging techniques in diagnosis and the identification of new genetic mutations in genes such as CLCN5, CASR, and SLC34A3 as significant factors contributing to the condition. The paper highlights the importance of recognizing these novel risk factors for better diagnosis, treatment, and prevention of nephrocalcinosis. It calls for further research to explore these new dimensions, particularly the genetic underpinnings and environmental exposures, to develop more effective management strategies and potentially prevent the onset of this complex renal condition,.
REFERENCES (39)
1.
Zacchia M, Capolongo G, Rinaldi L, Capasso G. The importance of the thick ascending limb of Henle’s loop in renal physiology and pathophysiology. Int J Nephrol Renovasc Dis 2018; 11: 81-92.
2.
Aldana JC, Rodríguez LC, Bastidas N, Vásquez A. Radiological features of nephrocalcinosis, a common but forgotten entity. Br J Radiol 2023; 96. DOI:
https://doi.org/10.1259/bjr.20....
3.
Benjamens S, Antunes IF, Hillebrands JL, et al. [18F]-sodium fluoride autoradiography imaging of nephrocalcinosis in donor kidneys and explanted kidney allografts. Sci Rep 2021; 11: 1841. DOI:
https://doi.org/10.1038/s41598....
5.
Colares Neto GP, Ide Yamauchi F, Hueb Baroni R, et al. Nephrocalcinosis and nephrolithiasis in X-linked hypophosphatemic rickets: diagnostic imaging and risk factors. J Endocr Soc 2019; 3: 1053-1061.
6.
Dickson FJ, Sayer JA. Nephrocalcinosis: a review of monogenic causes and insights they provide into this heterogeneous condition. Int J Mol Sci 2020; 21: 369. DOI:
https://doi.org/10.3390/ijms21....
7.
Daga A, Majmundar AJ, Braun DA, et al. Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis. Kidney Int 2018; 93: 204-213.
8.
Halbritter J, Baum M, Hynes AM, et al. Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis. J Am Soc Nephrol 2015; 26: 543-551.
10.
Sakakibara N, Nagano C, Ishiko S, et al. Comparison of clinical and genetic characteristics between Dent disease 1 and Dent disease 2. Pediatric Nephrol 2020; 35: 2319-2326.
11.
Blanchard A, Curis E, Guyon-Roger T, et al. Observations of a large Dent disease cohort. Kidney Int 2016; 90: 430-439.
12.
Mollataheri A, Mojbafan M, Hosseini R, et al. A Study on the CLCN5 gene in Iranian patients: a report of novel and recurrent mutations. Nephron 2023; 147: 470-477.
14.
Zung A, Barash G, Banne E, Levine MA. Novel calcium-sensing receptor (CASR) mutation in a family with autosomal dominant hypocalcemia type 1 (ADH1): genetic study over three generations and clinical characteristics. Horm Res Paediatr 2023; 96: 473-482.
15.
Lorenz-Depiereux B, Benet-Pages A, Eckstein G, et al. Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. Am J Hum Genet 2006; 78: 193-201.
16.
Dasgupta D, Wee MJ, Reyes M, et al. Mutations in SLC34A3/NPT2c are associated with kidney stones and nephrocalcinosis. J Am Soc Nephrol 2014; 25: 2366-2375.
17.
Schönauer R, Petzold F, Lucinescu W, et al. Evaluating pathogenicity of SLC34A3-Ser192Leu, a frequent European missense variant in disorders of renal phosphate wasting. Urolithiasis 2019; 47: 511-519.
18.
Nowicki JK, Maćkowska A, Rychwalska M, et al. Accidentally detected nephrocalcinosis in a boy with a homozygous R396W mutation in the CYP24A1 gene – 7-year follow-up. Pediatr Pol 2023; 98: 351-361.
19.
Rozhinskaya LYa, Pushkareva AS, Mamedova EO, et al. Parathyroid hormone-independent hypercalcemia and hypercalciuria of a patient with nephrolithiasis and nephrocalcinosis and impaired vitamin D metabolism due to a defect in the CYP24A1 gene. Osteoporosis and Bone Diseases 2021; 24: 26-33.
20.
Malakar S, Negi B, Singh G, Sharma T. Nephrocalcinosis in a patient with extrapulmonary tuberculosis – a rare entity. J Family Med Prim Care 2019; 8: 296. DOI:
https://doi.org/10.4103/jfmpc.....
21.
Saneifard H, Parviz S, Mohkam M, Jamee M. Hypercalcemia in distal renal tubular acidosis: A case report. J Clin Transl Endocrinol Case Rep 2020; 18: 100069. DOI:
https://doi.org/10.1016/j.jecr....
23.
Yadav M, Bagga A. Nephrocalcinosis: biochemical evaluation and genetic analysis. Indian Pediatr 2020; 57: 397-398.
24.
Hoppe B, von Unruh GE, Blank G, et al. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis. Am J Kidney Dis 2005; 46: 440-445.
25.
Garrelfs SF, Frishberg Y, Hulton SA, et al. Lumasiran, an RNAi therapeutic for primary hyperoxaluria type 1. N Engl J Med 2021; 384: 1216-1226.
26.
Jayachandran M, Yuzhakov SV, Kumar S, et al. Specific populations of urinary extracellular vesicles and proteins differentiate type 1 primary hyperoxaluria patients without and with nephrocalcinosis or kidney stones. Orphanet J Rare Dis 2020; 15: 319. DOI:
https://doi.org/10.1186/s13023....
27.
Ganesan C, Thomas I, Montez‐Rath ME, et al. Hypocitraturia and risk of bone disease in patients with kidney stone disease. JBMR Plus 2023; 7. DOI:
https://doi.org/10.1002/jbm4.1....
28.
Alexander RT, Cordat E, Chambrey R, et al. Acidosis and urinary calcium excretion: insights from genetic disorders. J Am Soc Nephrol 2016; 27: 3511-3520.
29.
Evenepoel P, Daenen K, Bammens B, et al. Microscopic nephrocalcinosis in chronic kidney disease patients. Nephrol Dial Transplant 2015; 30: 843-848.
30.
Imenez Silva PH, Wagner CA. Physiological relevance of proton-activated GPCRs. Pflugers Arch 2022; 474: 487-504.
31.
Saha S, Kandasamy D, Sharma R, et al. Nephrocalcinosis, renal dysfunction, and calculi in patients with primary hypoparathyroidism on long-term conventional therapy. J Clin Endocrinol Metab 2020; 105: e1215-e1224. DOI:
https://doi.org/10.1210/clinem....
32.
Yue H, Zhou P, Xu Z, et al. Effect of low-protein diet on kidney function and nutrition in nephropathy: a systematic review and meta-analysis of randomized controlled trials. Clin Nutr 2020; 39: 2675-2685.
33.
Courbebaisse M, Travers S, Bouderlique E, et al. Hydration for adult patients with nephrolithiasis: specificities and current recommendations. Nutrients 2023; 15: 4885. DOI:
https://doi.org/10.3390/nu1523....
34.
Wang JS, Chiang HY, Chen HL, et al. Association of water intake and hydration status with risk of kidney stone formation based on NHANES 2009-2012 cycles. Public Health Nutr 2022; 25: 2403-2414.
36.
Huynh M, Clark R, Li J, et al. A case control analysis investigating risk factors and outcomes for nephrocalcinosis and renal calculi in neonates. J Pediatr Urol 2017; 13: 356.e1-356.e5. DOI:
https://doi.org/10.1016/j.jpur....
37.
Zhang L, Ding F, Wang R, et al. Involvement of mitochondrial fission in renal tubular pyroptosis in mice exposed to high and environmental levels of glyphosate combined with hard water. Environ Pollut 2021; 283: 117082. DOI:
https://doi.org/10.1016/j.envp....
38.
Wu MY, Lo WC, Chao CT, et al. Association between air pollutants and development of chronic kidney disease: a systematic review and meta-analysis. Sci Total Environ 2020; 706: 135522. DOI:
https://doi.org/10.1016/j.scit....